What is the ticker symbol for Phathom Pharmaceuticals?

Phathom Pharmaceuticals trades under the ticker PHAT on NASDAQ.

What sector does Phathom Pharmaceuticals operate in?

Phathom Pharmaceuticals is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze PHAT in a portfolio?

PortView shows PHAT's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Phathom Pharmaceuticals (PHAT) Stock Analysis

NASDAQHealthcareBiotechnology

$9.12-2.90%

1-year price historyRange $8.23 – $18.08

52-week range$9.12

$8.21$18.31

What Phathom Pharmaceuticals does

Phathom Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical firm, dedicated to advancing and commercializing therapies for gastrointestinal ailments. A pivotal asset for the company is vonoprazan, a distinctive potassium-competitive acid blocker (P-CAB) designed to effectively inhibit gastric acid production, for which Phathom holds commercial rights across the United States, Europe, and Canada. This compound is currently undergoing advanced (Phase III) clinical trials for the treatment of erosive gastroesophageal reflux disease (GERD), and also as a component of combination therapy with antibiotics to combat Helicobacter pylori (H. pylori) infection. Established in 2018, Phathom Pharmaceuticals maintains its corporate headquarters in Florham Park, New Jersey.

Key metrics

Market cap

$737.63M

P/E (TTM)

-7.12

EPS (TTM)

$-1.28

Beta

0.50

Dividend yield

0.00%

Revenue / share

$2.86

50-day avg

$10.13

200-day avg

$12.15

52-week high

$18.31

52-week low

$8.21

CEO

Steven L. Basta

ETFs linked to PHAT

Broad-market and Healthcare sector ETFs an investor holding Phathom Pharmaceuticals is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how PHAT fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze PHAT in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Phathom Pharmaceuticals?: Phathom Pharmaceuticals trades under the ticker PHAT on NASDAQ.
Which exchange is PHAT listed on?: PHAT is listed on NASDAQ.
What sector does Phathom Pharmaceuticals operate in?: Phathom Pharmaceuticals is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze PHAT in a portfolio?: PortView shows PHAT's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.